First reported case of lysinuric pratein intolerance [LPI] in Lithuania, confirmed biochemically and DNA analysis

• Autorzy: Cimbalostiene L , Lehnert W. , Huopoen K. , Kucinskas V.
• Języki publikacji: EN

Abstrakty

EN

We report on an 18-year-old Lithuanian girl with hepatosplenomegaly noticed at birth, which progressed thereafter. The patient had to wait about 17 years for an accurate diagnosis and appropriate therapy. Lactase deficiency, congenital cataract of the right eye, and osteoporosis were observed. Episodes of drowsiness were caused by intake of high-protein food. Laboratory findings included slight hyperammonaemia, high plasma Citr, Ala, Gly, Glu, Ser levels, as well as citrullinuria, lysinuria, glutaminuria, alaninuria, argininuria, prolinuria, hydroxyprolinuria, ornithinuria, and orotic aciduria. Aversion to high-protein diet strongly suggested a disorder resulting in hyperammonaemia. Citrullinaemia was suspected. Subsequently the diagnosis ofLPI was made on the basis of biochemical and clinical features. Molecular genetic testing revealed a mutation in the SLC7A7 gene, confirming the diagnosis.

• Wydawca: -
• Czasopismo: Journal of Applied Genetics
• Rocznik: 2007
• Tom: 48
• Numer: 3
• Opis fizyczny: p.277-280,ref.

Twórcy

autor

Cimbalostiene L

• Vilnius University, Vilnius, Santariskiu 2, Lithuania

autor

Lehnert W.

autor

Huopoen K.

autor

Kucinskas V.

Bibliografia

• Borsani G, Bassi MT, Sperandeo MP, De Grandi A, Buoninconti A, Riboni M, et al. 1999. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet 21: 297-301.
• Borsani G, et al. 2000. Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance. Am J Hum Genet 66: 92-99.
• Desjeux J-F, Rajantie J, Simell O, Dumontier A-M, Perheentupa J, 1980. Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance. J Clin Invest 65: 1382-1387.
• Incerti B, Andria G, Parenti G, Sebastio G, Ghezzi M, Strisciugho P, Sperli D, 1993. Lysinuric protein intolerance: studies on 17 Italian patients. Am J Hum Genet Suppl 53: 908.
• Kato T, Mizutani N, Ban M, 1984. Hyperammonemia in lysinuric protein intolerance. Pediatrics 73: 489-492.
• Lauteala T, Sistonen P, Savontaus ML, Mykkanen J, Simell J, Lukkarinen M, Aula P, 1997. Lysinuric Protein Intolerance (LPI) gene maps to the long arm of chromosome 14. Am J Hum Genet 60: 1479-1486.
• Lukkarinen M, Nanto-Salonen K, Pulkki K, Aalto M, Simell O, 2003. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance. Metabolism 52: 935-938.
• Mannuci L, Emma F, Maeket M, Bachmas C, Boulat O, Carozzo R, Rizzoni G, Dionisi-Vici, 2005. Increased NO production in lysinuric protein intolerance. J Inherited Metab Dis 28: 123-129.
• Norio R, Visakorpi JK, 1965. Protein intolerance with deficient transport of basic amino acids. Lancet 2: 813.
• Norio R, Perheentupa J, Kekomaki M, Visakorpi JK, 1971. Lysinuric protein intolerance: an autosomal recessive disease. Clin Genet 2: 214.
• Parenti G, Sebastio G, Strisciuglio P, Incerti B, Pecoraro C, Terracciano L, Andria G, 1995. Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course. J Pediatr 126: 246-251.
• Perheentupa J, Visakorpi JK, 1965. Protein intolerance with deficient transport of basic amino acids: another inborn error of metabolism. Lancet 2: 813-816.
• Palacin M, Borsani G, Sebastio G, 2001. The molecular bases of cystinuria and lysinuric protein intolerance. Curr Opin Genet Dev 11: 328-335.
• Puomila K, Simell O, Huoponen K, Mykkanen J, 2006. Two alternative promoters regulate the expression of lysinuric protein intolerance gene SLC7A7. Mol Genet Metab: 28.
• Rajantie J, Simell O, Perheentupa J, 1980. Basolateral- membrane transport defect for lysine in lysinuric protein intolerance. Lancet 1: 1219.
• Rajantie J, Simell O, Perheentupa J, 1981. Basolateral-membrane transport defect for lysinuric protein intolerance. J Clin Invest 67: 1078-1082.
• Rajantie J, Simell O, Perheentupa J, 1983. Oral administration of n-acetyllysine and homocitrulline in lysinuric protein intolerance. J Pediatr 102: 388-390.
• Santamaría F, Parenti G, Guidi G, Rotondo A, Grillo G, Larocca MR, et al. 1996. Early detection of lung involvement in lysinuric protein intolerance: role of high-resolution computed tomography and radioisotopic methods. Am J Respir Crit Care Med 153: 731-735.
• Simell O, 2001. Lysinuric protein intolerance and other cationic aminoacidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th ed. New York, McGraw-Hill Medical Publication Division 3: 4933-4956.
• Shoj i Y, Noguchi A, Shoji Y, Matsumori M, Takasago Y, Takayanagi M, et al. 2002. Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance. Hum Mutat 20: 375-381.
• Sperandeo MP, Bassi MT, Riboni M, Parenti G, Buoninconti A, Manzoni M, et al. 2000. Structure of the SLC7A7 gene and mutation analysis of patients affected by lysinuric protein intolerance. Am J Hum Genet 66: 92-99.
• Sperandeo MP, Annunziata P, Ammendola V, Fiorito V, Pepe A, Soldovieri MV, et al. 2005. Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene. Hum Mutat 25: 410.
• Tanner LM, Nanto-Salonen K, Niinikovski H, Huoponen K, Simell O, 2007. Long-term oral lysine supplementation in lysinuric protein intolerance. Metabolism 56: 185-189.
• Torrents D, Mykkanen J, Pineda M, Feliubadalo L, Estevez R, de Cid R, et al. 1999. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. Nat Genet 21: 293-296.